MEDIA
Hanmi Using Proprietary mRNA Platform to Develop New Drugs for Refractory Cancer and Rare Diseases
Hanmi Pharmaceutical Group, which declared “Sustainable Innovation Management for a Pharmaceutical Powerhouse” as its management slogan for 2022, recently unveiled a new R&D ...
Hanmi Pharm Set to Produce DNA-based COVID-19 Vaccine Developed by Zydus Cadila
Hanmi Pharmaceutical announced that it would begin the production of ZyCoV-D, the COVID-19 plasmid DNA vaccine, developed by Indian pharmaceutical company Zydus Cadila (Zydus).
Hanmi Pharm Honored with the Presidential Award at the Korea Brand Awards
Hanmi Pharmaceutical announced that it had won the Presidential Award (Grand Prize) at the 23rd Korea Brand Awards hosted by the Ministry of Trade, Industry and Energy (MOTIE) at Novotel ...
Ofmom Korea Signs Sponsorship Agreement for Atopy Patients
On November 18th, Ofmom Korea (CEO Lucas Yoo) announced that it has entered into an agreement with the Korea Atopy Association to donate SynterAct, a probiotic product.
COREE partners with Infini Fluidics to develop new mRNA vaccine-making method
COREE Company, a member of Hanmi Science Consortium, has signed a strategic partnership agreement with Infini Fluidic of the U.S. to develop a new method in the microfluidic process producing ...
Chong Yoon Lim, CEO of Hanmi Science, announces addition of eWorldwide Group to Hanmi Science Consortium and invites other groups to join
As part of Hanmi Science’s continuing effort and investment in this area, Mr. Lim announced that eWorldwide Group has joined Hanmi Science Consortium. It is Mr. Lim’s hope that this global ...
Joint Marketing Campaign for Probiotic Supplement, SynterAct, and Postpartum Care Center, DeRAMA
A joint marketing campaign has been launched for SynterAct, a probiotic supplement consisting of 3P biotics developed for different age groups from babies to seniors, and DeRAMA.
Mamiai from Bejing Hanmi Pharmaceutical Wins over Countless Mothers in China
Mamiai, a probiotic supplement for promoting digestive health manufactured by Beijing Hanmi Pharmaceutical, has won over countless mothers across China and created a stepping-stone to ...
COREE Group, an Affiliate of Hanmi Science, "Promotes FDA Approval of One-to-One Customized Health Platform"
COREE Group, an affiliate of Hanmi Science, will push its own platform, "life intervention", into the US market with the ability to improve living habits and predict diseases. Its goal is to obtain a license for ...